Member Info for Sangijuelas1

Actually volume seems to be related to these 2 trades
01-Mar-23 10:18:48 368.20 494,422 Unknown* 2m O
01-Mar-23 10:17:05 368.20 494,422 Unknown* 2m O

Very strange

Over 1m traded already

Mentioned in WSJ article about chip start ups benefitting from the explosion of demand in AI following the interest in Chat GPT

https://www.google.com/amp/s/www.wsj.com/amp/articles/in-the-whirl-of-chatgpt-startups-see-an-opening-for-their-ai-chips-cb74798f

Yeah BeZero Carbon came out of that

Also no layoffs since scaling up to 550 staff.

Now looking to take on an additional 125

https://www.altfi.com/article/10464_thought-machine-to-expand-headcount-20-mostly-in-london

Accounts finally out for year ending 21. Revenue was up to £636m and net profit £26m.

They said revenues were over £850m for 22.

Still no staff cuts. They have recently said they are looking to take on 1700 staff.

Seem more optimistic about the time frame for UK banking license.

In the last interim results they said £90m of the debt facility had been drawn by 09/22.

That left £60m and there have been a quite a few investments over the last few months.

They are selling Trustpilot and they seem to have raised a bit from the Fund of Funds.

I would say they probably have about £20m left to play with.

Quite an interesting podcast with TM

https://www.mckinsey.com/industries/financial-services/our-insights/banks-core-technology-conundrum-reaches-an-inflection-point

A big part of the issue is being a tech company listed in London.
Tech is not popular in the least with fund managers. They believe everything is doomed to fail.

I believe US investors are looking more to Europe now. I think sooner or later they will come across MV and take an interest. Especially as companies doing well can't be accessed on public markets.

Obviously need to get the satellite up. Will be relying on SpaceX but looks like healthy interest for their early access programme.

Along with Iceye and Isar Aerospace they should benefit from the VC trend towards dual use tech that has defence capabilities along with civilian uses.

https://www.adsadvance.co.uk/satellite-vu-secures-81m-commitment-to-access-world-s-thermometer-.html

https://www.adsadvance.co.uk/satellite-vu-secures-81m-commitment-to-access-world-s-thermometer-.html

https://sifted.eu/articles/vc-investments-in-defence-startups/

https://hypemoon.com/2023/2/ledger-stax-incredible-demand-forces-pre-order-closure

Nice WSJ coverage of BeZero

https://www.wsj.com/articles/carbon-credit-raters-aim-to-assess-a-notoriously-opaque-market-11675717717

Jay Powell says Hi

Very interesting. Started looking at Twist Bio and a recent short seller report trashed their stock claiming it's a Theranos type fraud.

The report highlights Evonetix as one of 3-4 up and coming companies with better tech that are likely to pose an existential threat to Twist Bio's market.

Very interesting

Feel more optimistic about these 2 in the last few weeks.

Revolut have not had a firing round unlike many and also say they have plans to hire about 1700 staff over the next couple of years.

Graphcore could be a beneficiary if the Government get round to developing a semiconductor strategy. I doubt whether they have much in the way of long term ideas so the hope is they throw a few quid at the likes of Graphcore.

If they can't get Arm to list in London they might turn to GC.
Also might benefit from the rising Chat GPT tide. They are working with Aleph Alpha on an Open AI alternative.

It would be great to see us invest in AA as they are an Earlybird company

Often the valuations are a commercial secret.

At such an early stage I doubt the earlier raise would have been at that high a valuation as at that time they were still at proof of concept stage.

A comparator is Twist Bio listed on Nasdaq and market cap is over $1bn but they have annual revenues of over $200m.

Looks like Evo were cutting it fine as they only had cash up to end of the quarter.

I will need to take a closer look at Twist as their current valuation looks attractive.

Sorry $24m obviously

This has been one of my favourites from the portfolio. Company looking to commercialise their tech for providing researchers with synthetic DNA on a chip.

Despite the very difficult biotech market they have just raised $24bn in a round where Molten were able to hand over the lead investor role to Foresite Capital.

https://www.evonetix.com/2023-financing/

Scaling up production in house.

https://www.businessweekly.co.uk/tech-trail/tech-profiles/growth-works-supports-paragraf-make-wonder-material

https://www.businessweekly.co.uk/news/property-and-construction/paragraf-completes-lease-new-grade-industrial-space

This company which collapsed a few months ago was much worse. They were spending all the cash on wild staff parties and there is a class action lawsuit in the US to recover customers money.

https://sifted.eu/articles/pollen-refunds-events/